Databases with magnetic resonance neuroimaging of patients with COVID-19 in the period 2020-2021

Authors

Keywords:

COVID-19, database, magnetic resonance imaging, neuroimaging.

Abstract

COVID-19 is a disease that includes, among its sequelae, neurological affectations. Studies for its treatment require magnetic resonance imaging (MRI), obtained from patients with COVID-19. Therefore, it is necessary to have data to perform studies on the correlation between SARS-CoV-2 disease and neurological affections. This work aims to report the existence of databases with magnetic resonance neuroimaging of patients with COVID-19 in the period 2020-2021. For this purpose, a search for articles on COVID-19 published in PubMed and Science.gov databases between December 2019 and September 2021 was performed. The results demonstrated the scarce presence of online databases with MRI neuroimaging including subjects with COVID-19 and in the recovery stage. Given the situation created by this pandemic, there is a need for greater collaboration among neuroinvestigators, starting with the publication of accessible data.

Downloads

Download data is not yet available.

References

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5(4):536-44. DOI: https://doi.org/10.1038/s41564-020-0695-z

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579: 270-3. DOI: https://doi.org/10.1038/s41586-020-2012-7

Choi Y, Min Kyoung L. Neuroimaging findings of brain MRI and CT in patients with COVID-19: A systematic review and meta-analysis. European journal of radiology. 2020; 133:109393. DOI: https://doi.org/10.1016/j.ejrad.2020.109393

Lydia Chougar, Natalia Shor, Nicolas Weiss, Damien Galanaud, Delphine Leclercq, Bertrand Mathon, et al. Retrospective observational study of brain magnetic resonance imaging findings in patients with acute SARS-COV-2 infection and neurological manifestations. Radiology. 2020; 297(3):E313-E323. DOI: https://doi.org/10.1148/radiol.2020202422

Fátima M, Vasco V, Leal MC, Queiroga O, Moreira T, Moraes M. Anosmia in COVID-19 associated with injury to the olfactory bulbs evident on mri. American Journal of Neuroradiology. 2020; 41(9):1703-6. DOI: https://doi.org/10.3174/ajnr.A6675

Altundag A, Yıldırım D, Esin D, Cayonu M, Giray S, Necati A, et al. Olfactory cleft measurements and COVID-19–related anosmia. Otolaryngology–Head and Neck Surgery. 2020; 164(6):1337-44. DOI: https://doi.org/10.1177/0194599820965920

Qureshi AI, Baskett WI, Huang W, Shyu D, Myers D, Raju M, et al. Acute ischemic stroke and covid-19: An analysis of 27 676 patients. Stroke. 2020; 52(3):905-12, 2021. DOI: https://doi.org/10.1161/STROKEAHA.120.031786

Abildúa A, Atienza S, Monteiro G, Aguirre M, Aguayo L, Álvarez E, et al. Encefalopatías y encefalitis durante la infección aguda por SARS-CoV-2. Registro de la Sociedad Española de Neurología SEN COVID-19. Neurología (Barcelona, España); 2021. DOI: https://doi.org/10.1016/j.nrl.2020.11.013

Trejo-Gabriel-Galán JM. Ictus como complicación y como factor pronóstico de COVID-19. Neurología. 2020; 35(5):318-22. DOI: https://doi.org/10.1016/j.nrl.2020.04.015

Luxenburg O, Saban M, Myers V, Vaknin S, Boldor N, Wilf-Miron R. National and regional trends in mri utilization in the face of the ongoing COVID-19 pandemic. Israel Journal of Health Policy Research. 2021;10(1):1-10, 2021. DOI: https://doi.org/10.1186/s13584-021-00472-y

Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, Lange F, et al. Brain imaging before and after COVID-19 in UK Biobank. medRxiv [Preprint]. 2021;Jun 20:2021.06.11.21258690. DOI: https://doi.org/10.1101/2021.06.11.21258690

Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, et al. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs. patients with influenza. JAMA neurology, 77(11):1366-72, 2020. DOI: https://doi.org/10.1001/jamaneurol.2020.2730

Melanie RF Greenway, Young Erben, Josephine F Huang, Jason L Siegel, Christopher J Lamb, Mohammed K Badi, et al. Yield of head imaging in ambulatory and hospitalized patients with sars-cov-2: A multi-center study of 8675 patients. The Neurohospitalist. 2021 11(3):221-8. DOI: https://doi.org/10.1177/1941874420980622

Girardeau Y, Gallois Y, De Bonnecaze G, Escudé B, Lafont C, Chatellier G, et al. Confirmed central olfactory system lesions on brain mri in covid-19 patients with anosmia: a case-series. MedRxiv. 2020. DOI: https://doi.org/10.1101/2020.07.08.20148692 .

Paterson R, Brown R, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al. The emerging spectrum of covid-19 neurology: clinical, radiological and laboratory findings. Brain. 2020; 143(10):3104-20. DOI: https://doi.org/10.1093/brain/awaa240

Lindan CE, Mankad K, Ram D, Kociolek LK, Silvera VM, Boddaert N, et al. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. The Lancet Child & Adolescent Health. 2021; 5(3):167-77. DOI: https://doi.org/10.1016/S2352-4642(20)30362-X

Downloads

Published

2022-12-06

How to Cite

1.
Humara J, Alvarez Iglesias JE. Databases with magnetic resonance neuroimaging of patients with COVID-19 in the period 2020-2021. Rev. cuba. inf. cienc. salud [Internet]. 2022 Dec. 6 [cited 2025 Mar. 12];33. Available from: https://acimed.sld.cu/index.php/acimed/article/view/2161

Issue

Vol. 33 (2022): Publicación continua

Section

Sección temática: Ciencias de la información y COVID-19

License

Aquellos autores que tengan publicaciones con esta revista, aceptan los términos siguientes:

  1. Los autores conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
  2. Los autores podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un repositorio institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
  3. Se permite y recomienda a los autores difundir su obra a través de Internet (p. ej.: en repositorios institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto). En ese caso, solicitamos que en la cabecera del manuscrito se indique:"Esta es una versión preprint enviada a la Revista Cubana de Información en Ciencias de la Salud http://rcics.sld.cu/"

ENGLISH VERSION

AUTHORS WITH PUBLICATIONS IN THIS JOURNAL ACCEPT THE FOLLOWING TERMS:

  • Authors will retain their copyright and will grant the Journal the right of first publication of their work, which will also be subject to a Creative Commons  License Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) allowing third parties to share the work as long as the author's name and data about initial publication in this Journal are stated.
  • Authors may adopt other license agreements for non-exclusive distribution of the version of the work published (e.g. deposit it in an institutional repository or publish it in a monographic volume), as long as initial publication in this Journal is indicated.
  • It is permitted and recommended for authors to disseminate their work on the Internet (e.g. in institutional repositories or their web page) before and during the submission process, which may result in interesting exchanges and increase the number of citations of the published work) (see The effect of open access).